New
Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
EXV4 ETF · iShares STOXX Europe 600 Health Care UCITS ETF (DE)
The EXV4 Exchange Traded Fund (ETF) is provided by iShares. It is built to track an index: STOXX Europe 600 Health Care Index. The EXV4 ETF provides physical exposure, so by buying it you actually own parts of all the 51 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update 3/13/2026, 7:00 AM UTC
LIVE
CLOSED
This fund is part ofEurope Health Care1M perf.-9.37%
Last price
€112.18
1M perf.
-7.24%
1M flows
N/A
AuM
€703M
E/R
0.46%
Rating
ESG Consensus®
EXV4
€112.18
Performance & flows
Segment for quartile rank
December 15, 2025 → March 13, 2026
Create a free account to view the flows graph
EXV4
€112.35
+0.54%
Europe Health Care
-1.32%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -7.24%  | +0.54% | +1.89%  | +19.92% | +39.03% | -6.50% | -1.06% | -1.06% | |
| Flows |
Key fund info
Segment for quartile rank
Main characteristics
More details
NAV
3/13/2026
€112.35
1D NAV change
-0.13%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
51
Inception date
4/25/2001
Jurisdiction
Germany
Distribution
Switzerland
Germany
Austria
Hungary
Slovakia
Legal structure
SICAV
Base currency
EUR
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
The Fund seeks to track the performance of an index composed of companies from developed countries in Europe.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs
STW
1M perf.
-7.25%
E/R
0.18%
ESIH
1M perf.
-7.25%
E/R
0.18%
DXSE
1M perf.
-6.40%
E/R
0.17%
LHTC
1M perf.
-6.43%
E/R
0.3%
SC0T
1M perf.
-7.11%
E/R
0.2%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | +0.54% | +1.89%  | +19.92% | +39.03% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
1
2
3
4
5
6
7
PRIIPS
1
2
3
4
5
6
7
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
Switzerland
38.44%
United Kingdom
22.45%
Denmark
12.77%
France
11.38%
Germany
6.17%
Netherlands
4.17%
Belgium
2.09%
Unavailable
0.51%
Other
2.01%
Sectors
Health Care
78.26%
Consumer Discretionary
4.62%
Consumer Staples
2.23%
Materials
1.05%
Unavailable
13.83%
Diversification
Total weight of top 15 holdings out of 51
Top 15 holdings
Data as of January 31, 2026
ROCHE
ASTRAZENECA
NOVARTIS
DK0062498333
SANOFI SA
GSK PLC
ESSILORLUXOTTICA
ARGEN X NV
Create a free account to view top holdings
BAYER AG
LONZA GRP AG
HALEON PLC
ALCON INC
UCB
CH1243598427
CH1335392721
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
ESG Consensus® by Conser
Data as of December 31, 2025
MethodologyOur partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about EXV4 ETF's sustainability, based on their methodology.
ESG Consensus®
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
EXV4’s has a Final Sustainability Grade of either A+, A, or A-.
A+
A
A-
B+
B
B-
C+
C
C-
D
This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight EnterpriseHoldings review
91.09% of holdings have positive scoring
9.43% of holdings have negative scoring
80.59%
9.40%
Consensus levels
Strong
Medium
Weak
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseReplication
Trackinsight replication rating:
Replication quality
Calculated over 12m, as of February 27, 2026
Tracking error
Tracking difference
Replication information
Index
STOXX Europe 600 Health Care Net Return Index - EUR
Index ticker
SXDR Index
Index dividend policy
NTR
Replication method
Replication model
Built for professionals: access exclusive replication metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
iShares
iShares ID Card
Number of funds
1720
Total AuM
€4.9T
Expense ratio range
0.03% - 1.51%
Average expense ratio
0.285%
Top 5 funds by iShares
| AuM | ||
|---|---|---|
IVV | iShares Core S&P 500 ETF | €604.11B |
IEFA | iShares Core MSCI EAFE ETF | €145.9B |
AGG | iShares Core U.S. Aggregate Bond ETF | €120.51B |
IEMG | iShares Core MSCI Emerging Markets ETF | €118.19B |
CSSPX | iShares Core S&P 500 UCITS ETF | €112.42B |
Frequently asked questions about EXV4
What does iShares STOXX Europe 600 Health Care UCITS ETF (DE), EXV4, invest in?
EXV4 is a Passive ETF. This ETF provides exposure to European Health Care Equities.
Which benchmark or index does EXV4 replicate?
EXV4 tracks the STOXX Europe 600 Health Care Net Return Index - EUR, through a full replication replication method.
What is the Total Expense ratio (TER) of EXV4?
EXV4 carries a total expense ratio (TER) of 0.46%, indicating the annual cost for holding the fund.
When was EXV4 launched?
EXV4 was introduced to the market on April 25, 2001. It trades on Switzerland, among other exchanges
Who is the ETF issuer of EXV4?
iShares STOXX Europe 600 Health Care UCITS ETF (DE), EXV4, is provided by iShares. Learn more about iShares here.
What is the current assets under management (AUM) of EXV4?
EXV4 oversees €703M in assets as of March 13, 2026.
How has EXV4 performed lately?
Based on data from March 13, 2026, EXV4 returned -7.24% over the past month, 0.54% over the last three months and -1.06% year-to-date.
What are the latest inflows or outflows for EXV4?
As of March 13, 2026, EXV4 recorded net flows of -€5.5M year-to-date.
Does EXV4 distribute dividends?
EXV4 follows a distributing dividend policy, meaning it pays out income to investors. As of March 13, 2026, its 12-month trailing yield was 1.60%.
What are the main country or region exposures of EXV4?
As of January 31, 2026, EXV4 has significant geographic allocations in Switzerland, United Kingdom and Denmark.
In which sector or theme does EXV4 invest in?
As of January 31, 2026, EXV4 focuses largely on Health Care, Consumer Discretionary and Consumer Staples.
How many securities does EXV4 hold and how diversified is it?
As of January 31, 2026, EXV4 holds 51 positions in its portfolio, with 83.84% of assets concentrated in its top 15 holdings.
What are the main positions in EXV4?
As of January 31, 2026, EXV4 top three holdings include ROCHE, ASTRAZENECA and NOVARTIS.
What is the base currency of EXV4?
The base currency of EXV4 is EUR.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
